Radiation therapy for cancers of the head and neck can irreversibly damage the salivary glands. Xerostomia (subjective oral dryness) develops within the first week of therapy and is progressive, with devastating effects on the quality of life of the individual. The xerostomia does not correlate with the degree of salivary gland hypofunction. The mechanism of tissue injury in humans is still unclear, but much progress has been made with animal models. This paper reviews the natural history of radiation damage to human salivary glands and highlights the inter-individual variations in the responses to and recovery from therapeutic radiation. The degree of salivary gland damage is correlated to the dose of radiation delivered and the volume of gland included in the field of radiation. The molecular mechanism of acute radiation damage is not fully understood; however, long-term salivary gland dysfunction is associated with both loss of gland weight and loss of acinar cells. Various strategies have been used to prevent or alleviate the problem of salivary gland hypofunction following therapeutic radiation. This paper reviews the progress made to date and the possibilities for future interventions to prevent radiation damage.
Abok K., Brunk U., Jung B., Ericsson J. (1984). Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland . Virchows Arch B Cell Pathol Incl Mol Pathol45:443-460.
2.
Anderson MW, Izutsu KT, Rice JC ( 1981). Parotid gland pathophysiology after mixed gamma and neutron irradiation of cancer patients. Oral Surg Oral Med Oral Pathol52:495-500.
3.
Ballagh RH, Kudryk KG, Lampe HB, Moriarty B., Mackay A., Burford-Mason AP, et al. (1994). The pathobiology of salivary gland. III. PCNA-localization of cycling cells induced in rat submandibular gland by low-dose x-radiation. Oral Surg Oral Med Oral Pathol77:27-35.
4.
Brown LR, Dreizen S., Rider LJ, Johnston DA (1976). The effect of radiation-induced xerostomia on saliva and serum lysozyme and immunoglobulin levels. Oral Surg Oral Med Oral Pathol41:83-92.
5.
Buchsbaum DJ, Raben D., Stackhouse MA, Khazaeli MB, Rogers BE, Rosenfeld ME, et al. (1996). Approaches to enhance cancer radiotherapy employing gene transfer methods. Gene Ther3:1042-1068.
6.
Cheng VS, Downs J., Herbert D., Aramany M. (1981). The function of the parotid gland following radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys7:253-258.
7.
Coppes RP, Vissink A., Zeilstra LJ, Konings AW (1997a). Muscarinic receptor stimulation increases tolerance of rat salivary gland function to radiation damage. Int J Radiat Biol72:615-625.
8.
Coppes RP, Zeilstra LJ, Vissink A., Konings AW (1997b). Sialogogue-related radioprotection of salivary gland function: the degranulation concept revisited. Radiat Res148:240-247.
9.
Coppes RP, Roffel AF, Zeilstra LJ, Vissink A., Konings AW (2000). Early radiation effects on muscarinic receptor-induced secretory responsiveness of the parotid gland in the freely moving rat. Radiat Res153:339-346.
10.
D'Hondt E., Eisbruch A., Ship JA ( 1998). The influence of pre-radiation salivary flow rates and radiation dose on parotid salivary gland dysfunction in patients receiving radiotherapy for head and neck cancers. Spec Care Dentist18:102-108.
11.
Delporte C., O'Connell BC, He X., Lancaster HE, O'Connell AC, Agre P., et al. (1997). Increased fluid secretion after adenoviralmediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci USA94:3268-3273.
12.
Dreizen S., Daly TE, Drane JB, Brown LR (1977). Oral complications of cancer radiotherapy. Postgrad Med61:85-92.
13.
Eisbruch A., Ship JA, Martel MK, Ten Haken RK, Marsh LH, Wolf GT, et al. (1996). Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys36:469-480.
14.
Eisbruch A., Dawson LA, Kim HM, Bradford CR, Terrell JE, Chepeha DB, et al. (1999a). Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg53:271-275.
15.
Eisbruch A., Ten Haken RK, Kim HM, Marsh LH, Ship JA ( 1999b). Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys45:577-587.
16.
El-Mofty SK, Kahn AJ ( 1981). Early membrane injury in lethally irradiated salivary gland cells. Int J Radiat Biol Relat Stud Phys Chem Med39:55-62.
17.
Fox PC (1987). Systemic therapy of salivary gland hypofunction . J Dent Res66(Spec Iss):689-692.
18.
Fox PC, Busch KA, Baum BJ ( 1987). Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc115:581-584.
19.
Fox PC, Atkinson JC, Macynski AA, Wolff A., Kung DS, Valdez IH, et al. (1991). Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med151:1149-1152.
20.
Franzen L., Funegard U., Ericson T., Henriksson R. (1992). Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. Eur J Cancer28:457-462.
21.
Funegard U., Franzen L., Ericson T., Henriksson R. (1994). Parotid saliva composition during and after irradiation of head and neck cancer. Eur J Cancer B Oral Oncol30(B):230-233.
22.
Guchelaar HJ, Vermes A., Meerwaldt JH (1997). Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment [see comments]. Support Care Cancer5:281-288.
23.
Henriksson R., Frojd O., Gustafsson H., Johansson S., Yi-Qing C., Franzen L., et al. (1994). Increase in mast cells and hyaluronic acid correlates to radiation-induced damage and loss of serous acinar cells in salivary glands: the parotid and submandibular glands differ in radiation sensitivity. Br J Cancer69:320-326.
24.
Hiramatsu Y., Nagler RM, Fox PC, Baum BJ ( 1994). Rat salivary gland blood flow and blood-to-tissue partition coefficients following x-irradiation. Arch Oral Biol39:77-80.
25.
Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D., et al. (1993). Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer [see comments]. N Engl J Med329:390-395.
26.
Kashima H., Kirkham W., Andrews J. (1965). Postirradiation sialadenitis. Am J Roentgenol94:271-291.
27.
Kohn WG, Grossman E., Fox PC, Armando I., Goldstein DS, Baum BJ ( 1992). Effect of ionizing radiation on sympathetic nerve function in rat parotid glands. J Oral Pathol Med21:134-137.
28.
Leslie MD, Dische S. (1994). The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiother Oncol30:26-32.
29.
LeVeque FG, Montgomery M., Potter D., Zimmer MB, Rieke JW, Steiger BW, et al. (1993). A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol11:1124-1131.
30.
Liem IH, Olmos RAV, Balm AJM, Keus RB, van Tinteren H., Takes RP, et al. (1996). Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours. Eur J Nucl Med23:1485-1490.
31.
Liu RP, Fleming TJ, Toth BB, Keene HJ (1990). Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy. Oral Surg Oral Med Oral Pathol70:724-729.
32.
Mandel ID (1987). The functions of saliva. J Dent Res66(Spec Iss):623-627.
33.
Marks JE, Davis CC, Gottsman VL, Purdy JE, Lee F. (1981). The effects of radiation on parotid salivary function . Int J Radiat Oncol Biol Phys7:1013-1019.
34.
Mealey BL, Semba SE, Hallmon WW (1994). The head and neck radiotherapy patient: Part 2-Management of oral complications. Compend Contin Educ Dentist15:442, 444, 446-452 passim; quiz 458.
35.
Mira JG, Wescott WB, Starcke EN, Shannon IL (1981). Some factors influencing salivary function when treating with radiotherapy. Int J Radiat Oncol Biol Phys7:535-541.
36.
Mira JG, Fullerton GD, Wescott WB (1982). Correlation between initial salivary flow rate and radiation dose in the production of xerostomia. Acta Radiol Oncol21:151-154.
37.
Mossman K., Shatzman A., Chencharick J. (1982). Long-term effects of radiotherapy on taste and salivary function in man. Int J Radiat Oncol Biol Phys8:991-997.
38.
Nagler RM, Laufer D. (1998). Protection against irradiation-induced damage to salivary glands by adrenergic agonist administration. Int J Radiat Oncol Biol Phys40:477-481.
39.
Nagler R., Marmary Y., Fox PC, Baum BJ, Har-El R., Chevion M. (1997). Irradiation-induced damage to the salivary glands: the role of redox-active iron and copper. Radiat Res147:468-476.
40.
Nagler R., Marmary Y., Golan E., Chevion M. (1998). Novel protection strategy against x-ray-induced damage to salivary glands. Radiat Res149:271-276.
41.
Niedermeier W., Matthaeus C., Meyer C., Staar S., Muller RP, Schulze HJ (1998). Radiation-induced hyposalivation and its treatment with oral pilocarpine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod86:541-549.
42.
O'Connell AC, Baccaglini L., Fox PC, O'Connell BC, Kenshalo D., Oweisy H., et al. (1999a). Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates. Cancer Gene Ther6:505-513.
43.
O'Connell AC, Redman RS, Evans RL, Ambudkar IS (1999b). Radiation-induced progressive decrease in fluid secretion in rat submandibular glands is related to decreased acinar volume and not impaired calcium signaling. Radiat Res151:150-158.
44.
Peter B., Van Waarde MA, Vissink A., 's-Gravenmade EJ, Konings AW (1994a). Radiation-induced cell proliferation in the parotid and submandibular glands of the rat. Radiat Res140:257-265.
45.
Peter B., Van Waarde MA, Vissink A., 's-Gravenmade EJ, Konings AW (1994b). The role of secretory granules in the radiosensitivity of rat salivary gland acini-a morphological study. Radiat Res140:419-428.
46.
Rieke JW, Hafermann MD, Johnson JT, LeVeque FG, Iwamoto R., Steiger BW, et al. (1995). Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiat Oncol Biol Phys31:661-669.
47.
Roesink JM, Konings AW, Terhaard CH, Battermann JJ, Kampinga HH, Coppes RP (1999). Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: radiation dose dependency and compensatory mechanisms. Int j Radiat Oncol Biol Phys45:483-489.
48.
Rothwell BR (1987). Prevention and treatment of the orofacial complications of radiotherapy. J Am Dent Assoc114:316-322.
49.
Semba SE, Mealey BL, Hallmon WW (1994). The head and neck radiotherapy patient: Part 1-Oral manifestations of radiation therapy. Compend Contin Educ Dentist15:250, 252-260; quiz 261.
50.
Shannon IL, Starcke EN, Wescott WB (1977). Effect of radiotherapy on whole saliva flow. J Dent Res56:693.
51.
Ship JA, Eisbruch A., D'Hondt E., Jones RE (1997). Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: one-year results. J Dent Res76:807-813.
52.
Sholley MM, Sodicoff M., Pratt NE (1974). Early radiation injury in the rat parotid gland. Reaction of acinar cells and vascular endothelium. Lab Invest31:340-354.
53.
Stephens LC, Ang KK, Schultheiss TE, King GK, Brock WA, Peters LJ (1986a). Target cell and mode of radiation injury in rhesus salivary glands. Radiother Oncol7:165-174.
54.
Stephens LC, King GK, Peters LJ, Ang KK, Schultheiss TE, Jardine JH (1986b). Unique radiosensitivity of serous cells in rhesus monkey submandibular glands. Am J Pathol124:479-487.
55.
Stephens LC, Schultheiss TE, Price RE, Ang KK, Peters LJ (1991). Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer67:1539-1543.
56.
Taylor SE, Miller EG (1999). Preemptive pharmacologic intervention in radiation-induced salivary dysfunction. Proc Soc Exp Biol Med221:14-26.
57.
Valdez IH (1991). Radiation-induced salivary dysfunction: clinical course and significance. Spec Care Dentist11:252-255.
58.
Valdez IH, Atkinson JC, Ship JA, Fox PC (1993a). Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int J Radiat Oncol Biol Phys25:41-47.
59.
Valdez IH, Wolff A., Atkinson JC, Macynski AA, Fox PC (1993b). Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer71 :1848-1851.
60.
Vissink A., 's-Gravenmade EJ, Ligeon EE, Konings WT (1990). A functional and chemical study of radiation effects on rat parotid and submandibular/sublingual glands. Radiat Res124:259-265.
61.
Vissink A., Kalicharan D., 's-Gravenmade EJ, Jongebloed WL, Ligeon EE, Nieuwenhuis P., et al. (1991). Acute irradiation effects on morphology and function of rat submandibular glands. J Oral Pathol Med20:449-456.
62.
Vissink A., Down JD, Konings AW (1992). Contrasting dose-rate effects of gamma-irradiation on rat salivary gland function. Int J Radiat Biol61:275-282.
63.
Wescott WB, Mira JG, Starcke EN, Shannon IL, Thornby JI (1978). Alterations in whole saliva flow rate induced by fractionated radiotherapy. AJR Am J Roentgenol130:145-149.
64.
Zimmerman RP, Mark RJ, Tran LM, Juillard GF (1997). Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys37:571-575.
